Stocks Health care TMDX
NASDAQ · Health careTransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. brought in $668.5M of revenue over the twelve months to June 30, 2026, up 25.8% from a year earlier. Net income was $151.7M, a net margin of 22.7%. Operating cash flow minus capital spending left $133.6M of free cash flow in fiscal 2025. At June 30, 2026 it held $491.1M in cash against $20M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 4, 2026.
What TransMedics Group, Inc. does
TransMedics Group, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker TMDX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $605.5M | $190.3M | $4.87 | $133.6M |
| 2024 | $441.5M | $35.5M | $1.01 | -$80.9M |
| 2023 | $241.6M | -$25M | -$0.77 | -$164.9M |
| 2022 | $93.5M | -$36.2M | -$1.23 | -$57.7M |
| 2021 | $31.4M | -$44.2M | -$1.60 | -$32.4M |
| 2020 | $28.4M | -$28.7M | -$1.16 | -$30.7M |
Latest SEC filings
What TransMedics Group, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 10, 2026
- August 4, 2026Quarterly report 10-Q · period to June 30, 2026
- August 4, 2026
- May 29, 2026
- May 21, 2026
- May 7, 2026Additional proxy material DEFA14A
- May 5, 2026Quarterly report 10-Q · period to March 31, 2026
- May 5, 2026
- April 30, 2026Passive stake (5% or more) SCHEDULE 13G
- April 29, 2026Passive stake (5% or more) SCHEDULE 13G
Questions about TMDX
What does TransMedics Group, Inc. do?
TransMedics Group, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker TMDX.
Is TransMedics Group, Inc. profitable?
Yes. Over the twelve months to June 30, 2026 it reported net income of $151.7M on revenue of $668.5M, a net margin of 22.7%.
How much revenue does TransMedics Group, Inc. make?
Over the twelve months to June 30, 2026 TransMedics Group, Inc. reported revenue of $668.5M. That is 25.8% more than a year earlier.
When did TransMedics Group, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 4, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the insider trade from September 14, 2026.
Similar companies
Follow TMDX
Get an email when TransMedics Group, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow TMDX: get an email when it filesWhere the numbers come from
Financial figures are the values TransMedics Group, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.